Global Chorea Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309814
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Chorea Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Chorea Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Chorea Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Medication segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Chorea Treatment include Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Chorea Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Medication

Surgery Therapy

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

Medtronic

Boston Scientific

Aleva Neurotherapeutics

Teva Pharmaceutical

Pfizer

GlaxoSmithKline

Bausch Health Companies

LivaNova

Lundbeck

Ipsen

Alnylam Pharmaceuticals

Prana Biotechnology

RespireRx Pharmaceuticals

Vertex Pharmaceuticals

SOM Biotech

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Chorea Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Chorea Treatment, with revenue, gross margin and global market share of Chorea Treatment from 2019 to 2022.

Chapter 3, the Chorea Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Chorea Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Chorea Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Chorea Treatment

1.2 Classification of Chorea Treatment by Type

1.2.1 Overview: Global Chorea Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Chorea Treatment Revenue Market Share by Type in 2021

1.2.3 Medication

1.2.4 Surgery Therapy

1.3 Global Chorea Treatment Market by Application

1.3.1 Overview: Global Chorea Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Chorea Treatment Market Size & Forecast

1.5 Global Chorea Treatment Market Size and Forecast by Region

1.5.1 Global Chorea Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Chorea Treatment Market Size by Region, (2017-2022)

1.5.3 North America Chorea Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Chorea Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Chorea Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Chorea Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Chorea Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Chorea Treatment Market Drivers

1.6.2 Chorea Treatment Market Restraints

1.6.3 Chorea Treatment Trends Analysis

2 Company Profiles

2.1 Medtronic

2.1.1 Medtronic Details

2.1.2 Medtronic Major Business

2.1.3 Medtronic Chorea Treatment Product and Solutions

2.1.4 Medtronic Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Medtronic Recent Developments and Future Plans

2.2 Boston Scientific

2.2.1 Boston Scientific Details

2.2.2 Boston Scientific Major Business

2.2.3 Boston Scientific Chorea Treatment Product and Solutions

2.2.4 Boston Scientific Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Boston Scientific Recent Developments and Future Plans

2.3 Aleva Neurotherapeutics

2.3.1 Aleva Neurotherapeutics Details

2.3.2 Aleva Neurotherapeutics Major Business

2.3.3 Aleva Neurotherapeutics Chorea Treatment Product and Solutions

2.3.4 Aleva Neurotherapeutics Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Aleva Neurotherapeutics Recent Developments and Future Plans

2.4 Teva Pharmaceutical

2.4.1 Teva Pharmaceutical Details

2.4.2 Teva Pharmaceutical Major Business

2.4.3 Teva Pharmaceutical Chorea Treatment Product and Solutions

2.4.4 Teva Pharmaceutical Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Teva Pharmaceutical Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Chorea Treatment Product and Solutions

2.5.4 Pfizer Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 GlaxoSmithKline

2.6.1 GlaxoSmithKline Details

2.6.2 GlaxoSmithKline Major Business

2.6.3 GlaxoSmithKline Chorea Treatment Product and Solutions

2.6.4 GlaxoSmithKline Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 GlaxoSmithKline Recent Developments and Future Plans

2.7 Bausch Health Companies

2.7.1 Bausch Health Companies Details

2.7.2 Bausch Health Companies Major Business

2.7.3 Bausch Health Companies Chorea Treatment Product and Solutions

2.7.4 Bausch Health Companies Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bausch Health Companies Recent Developments and Future Plans

2.8 LivaNova

2.8.1 LivaNova Details

2.8.2 LivaNova Major Business

2.8.3 LivaNova Chorea Treatment Product and Solutions

2.8.4 LivaNova Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 LivaNova Recent Developments and Future Plans

2.9 Lundbeck

2.9.1 Lundbeck Details

2.9.2 Lundbeck Major Business

2.9.3 Lundbeck Chorea Treatment Product and Solutions

2.9.4 Lundbeck Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Lundbeck Recent Developments and Future Plans

2.10 Ipsen

2.10.1 Ipsen Details

2.10.2 Ipsen Major Business

2.10.3 Ipsen Chorea Treatment Product and Solutions

2.10.4 Ipsen Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Ipsen Recent Developments and Future Plans

2.11 Alnylam Pharmaceuticals

2.11.1 Alnylam Pharmaceuticals Details

2.11.2 Alnylam Pharmaceuticals Major Business

2.11.3 Alnylam Pharmaceuticals Chorea Treatment Product and Solutions

2.11.4 Alnylam Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Alnylam Pharmaceuticals Recent Developments and Future Plans

2.12 Prana Biotechnology

2.12.1 Prana Biotechnology Details

2.12.2 Prana Biotechnology Major Business

2.12.3 Prana Biotechnology Chorea Treatment Product and Solutions

2.12.4 Prana Biotechnology Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Prana Biotechnology Recent Developments and Future Plans

2.13 RespireRx Pharmaceuticals

2.13.1 RespireRx Pharmaceuticals Details

2.13.2 RespireRx Pharmaceuticals Major Business

2.13.3 RespireRx Pharmaceuticals Chorea Treatment Product and Solutions

2.13.4 RespireRx Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 RespireRx Pharmaceuticals Recent Developments and Future Plans

2.14 Vertex Pharmaceuticals

2.14.1 Vertex Pharmaceuticals Details

2.14.2 Vertex Pharmaceuticals Major Business

2.14.3 Vertex Pharmaceuticals Chorea Treatment Product and Solutions

2.14.4 Vertex Pharmaceuticals Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Vertex Pharmaceuticals Recent Developments and Future Plans

2.15 SOM Biotech

2.15.1 SOM Biotech Details

2.15.2 SOM Biotech Major Business

2.15.3 SOM Biotech Chorea Treatment Product and Solutions

2.15.4 SOM Biotech Chorea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 SOM Biotech Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Chorea Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Chorea Treatment Players Market Share in 2021

3.2.2 Top 10 Chorea Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Chorea Treatment Players Head Office, Products and Services Provided

3.4 Chorea Treatment Mergers & Acquisitions

3.5 Chorea Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Chorea Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Chorea Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Chorea Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Chorea Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Chorea Treatment Revenue by Type (2017-2028)

6.2 North America Chorea Treatment Revenue by Application (2017-2028)

6.3 North America Chorea Treatment Market Size by Country

6.3.1 North America Chorea Treatment Revenue by Country (2017-2028)

6.3.2 United States Chorea Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Chorea Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Chorea Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Chorea Treatment Revenue by Type (2017-2028)

7.2 Europe Chorea Treatment Revenue by Application (2017-2028)

7.3 Europe Chorea Treatment Market Size by Country

7.3.1 Europe Chorea Treatment Revenue by Country (2017-2028)

7.3.2 Germany Chorea Treatment Market Size and Forecast (2017-2028)

7.3.3 France Chorea Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Chorea Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Chorea Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Chorea Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Chorea Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Chorea Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Chorea Treatment Market Size by Region

8.3.1 Asia-Pacific Chorea Treatment Revenue by Region (2017-2028)

8.3.2 China Chorea Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Chorea Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Chorea Treatment Market Size and Forecast (2017-2028)

8.3.5 India Chorea Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Chorea Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Chorea Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Chorea Treatment Revenue by Type (2017-2028)

9.2 South America Chorea Treatment Revenue by Application (2017-2028)

9.3 South America Chorea Treatment Market Size by Country

9.3.1 South America Chorea Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Chorea Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Chorea Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Chorea Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Chorea Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Chorea Treatment Market Size by Country

10.3.1 Middle East & Africa Chorea Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Chorea Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Chorea Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Chorea Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Chorea Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Chorea Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Chorea Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Chorea Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Chorea Treatment Revenue Market Share by Region (2023-2028)

Table 6. Medtronic Corporate Information, Head Office, and Major Competitors

Table 7. Medtronic Major Business

Table 8. Medtronic Chorea Treatment Product and Solutions

Table 9. Medtronic Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Boston Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Boston Scientific Major Business

Table 12. Boston Scientific Chorea Treatment Product and Solutions

Table 13. Boston Scientific Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Aleva Neurotherapeutics Corporate Information, Head Office, and Major Competitors

Table 15. Aleva Neurotherapeutics Major Business

Table 16. Aleva Neurotherapeutics Chorea Treatment Product and Solutions

Table 17. Aleva Neurotherapeutics Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 19. Teva Pharmaceutical Major Business

Table 20. Teva Pharmaceutical Chorea Treatment Product and Solutions

Table 21. Teva Pharmaceutical Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Chorea Treatment Product and Solutions

Table 25. Pfizer Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 27. GlaxoSmithKline Major Business

Table 28. GlaxoSmithKline Chorea Treatment Product and Solutions

Table 29. GlaxoSmithKline Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bausch Health Companies Corporate Information, Head Office, and Major Competitors

Table 31. Bausch Health Companies Major Business

Table 32. Bausch Health Companies Chorea Treatment Product and Solutions

Table 33. Bausch Health Companies Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. LivaNova Corporate Information, Head Office, and Major Competitors

Table 35. LivaNova Major Business

Table 36. LivaNova Chorea Treatment Product and Solutions

Table 37. LivaNova Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Lundbeck Corporate Information, Head Office, and Major Competitors

Table 39. Lundbeck Major Business

Table 40. Lundbeck Chorea Treatment Product and Solutions

Table 41. Lundbeck Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Ipsen Corporate Information, Head Office, and Major Competitors

Table 43. Ipsen Major Business

Table 44. Ipsen Chorea Treatment Product and Solutions

Table 45. Ipsen Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Alnylam Pharmaceuticals Major Business

Table 48. Alnylam Pharmaceuticals Chorea Treatment Product and Solutions

Table 49. Alnylam Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Prana Biotechnology Corporate Information, Head Office, and Major Competitors

Table 51. Prana Biotechnology Major Business

Table 52. Prana Biotechnology Chorea Treatment Product and Solutions

Table 53. Prana Biotechnology Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. RespireRx Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. RespireRx Pharmaceuticals Major Business

Table 56. RespireRx Pharmaceuticals Chorea Treatment Product and Solutions

Table 57. RespireRx Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Vertex Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. Vertex Pharmaceuticals Major Business

Table 60. Vertex Pharmaceuticals Chorea Treatment Product and Solutions

Table 61. Vertex Pharmaceuticals Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. SOM Biotech Corporate Information, Head Office, and Major Competitors

Table 63. SOM Biotech Major Business

Table 64. SOM Biotech Chorea Treatment Product and Solutions

Table 65. SOM Biotech Chorea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Chorea Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Chorea Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Chorea Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Chorea Treatment Players Head Office, Products and Services Provided

Table 70. Chorea Treatment Mergers & Acquisitions in the Past Five Years

Table 71. Chorea Treatment New Entrants and Expansion Plans

Table 72. Global Chorea Treatment Revenue (USD Million) by Type (2017-2022)

Table 73. Global Chorea Treatment Revenue Share by Type (2017-2022)

Table 74. Global Chorea Treatment Revenue Forecast by Type (2023-2028)

Table 75. Global Chorea Treatment Revenue by Application (2017-2022)

Table 76. Global Chorea Treatment Revenue Forecast by Application (2023-2028)

Table 77. North America Chorea Treatment Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Chorea Treatment Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Chorea Treatment Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Chorea Treatment Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Chorea Treatment Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Chorea Treatment Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Chorea Treatment Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Chorea Treatment Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Chorea Treatment Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Chorea Treatment Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Chorea Treatment Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Chorea Treatment Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Chorea Treatment Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Chorea Treatment Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Chorea Treatment Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Chorea Treatment Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Chorea Treatment Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Chorea Treatment Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Chorea Treatment Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Chorea Treatment Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Chorea Treatment Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Chorea Treatment Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Chorea Treatment Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Chorea Treatment Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Chorea Treatment Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Chorea Treatment Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Chorea Treatment Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Chorea Treatment Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Chorea Treatment Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Chorea Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Chorea Treatment Picture

Figure 2. Global Chorea Treatment Revenue Market Share by Type in 2021

Figure 3. Medication

Figure 4. Surgery Therapy

Figure 5. Chorea Treatment Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Clinics Picture

Figure 8. Others Picture

Figure 9. Global Chorea Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Chorea Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Chorea Treatment Revenue Market Share by Region (2017-2028)

Figure 12. Global Chorea Treatment Revenue Market Share by Region in 2021

Figure 13. North America Chorea Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Chorea Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Chorea Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Chorea Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Chorea Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Chorea Treatment Market Drivers

Figure 19. Chorea Treatment Market Restraints

Figure 20. Chorea Treatment Market Trends

Figure 21. Medtronic Recent Developments and Future Plans

Figure 22. Boston Scientific Recent Developments and Future Plans

Figure 23. Aleva Neurotherapeutics Recent Developments and Future Plans

Figure 24. Teva Pharmaceutical Recent Developments and Future Plans

Figure 25. Pfizer Recent Developments and Future Plans

Figure 26. GlaxoSmithKline Recent Developments and Future Plans

Figure 27. Bausch Health Companies Recent Developments and Future Plans

Figure 28. LivaNova Recent Developments and Future Plans

Figure 29. Lundbeck Recent Developments and Future Plans

Figure 30. Ipsen Recent Developments and Future Plans

Figure 31. Alnylam Pharmaceuticals Recent Developments and Future Plans

Figure 32. Prana Biotechnology Recent Developments and Future Plans

Figure 33. RespireRx Pharmaceuticals Recent Developments and Future Plans

Figure 34. Vertex Pharmaceuticals Recent Developments and Future Plans

Figure 35. SOM Biotech Recent Developments and Future Plans

Figure 36. Global Chorea Treatment Revenue Share by Players in 2021

Figure 37. Chorea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Chorea Treatment Revenue Market Share in 2021

Figure 39. Global Top 10 Players Chorea Treatment Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Chorea Treatment Revenue Share by Type in 2021

Figure 42. Global Chorea Treatment Market Share Forecast by Type (2023-2028)

Figure 43. Global Chorea Treatment Revenue Share by Application in 2021

Figure 44. Global Chorea Treatment Market Share Forecast by Application (2023-2028)

Figure 45. North America Chorea Treatment Sales Market Share by Type (2017-2028)

Figure 46. North America Chorea Treatment Sales Market Share by Application (2017-2028)

Figure 47. North America Chorea Treatment Revenue Market Share by Country (2017-2028)

Figure 48. United States Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Chorea Treatment Sales Market Share by Type (2017-2028)

Figure 52. Europe Chorea Treatment Sales Market Share by Application (2017-2028)

Figure 53. Europe Chorea Treatment Revenue Market Share by Country (2017-2028)

Figure 54. Germany Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Chorea Treatment Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Chorea Treatment Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Chorea Treatment Revenue Market Share by Region (2017-2028)

Figure 62. China Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Chorea Treatment Sales Market Share by Type (2017-2028)

Figure 69. South America Chorea Treatment Sales Market Share by Application (2017-2028)

Figure 70. South America Chorea Treatment Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Chorea Treatment Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Chorea Treatment Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Chorea Treatment Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Chorea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz